EClinicalMedicine, 75, 102782
Once considered to act primarily through reductions in albuminuria, GLP-1RAs now have dedicated hard-endpoint evidence: in the FLOW trial, semaglutide reduced the primary composite kidney outcome ( 50% eGFR decline, kidney failure, or kidney or cardiovascular death) by 24% (hazard ratio 0.76, 95% CI 0.660.88) in type 2 diabetes and CKD and slowed eGFR decline [48, 49]
10.1016/S0021-9258(19)77830-2 24 HildebrandtT
Christy even mentions, "There's actually a compounding pharmacy that I refuse to use because it's had several safety concerns." RELATED: 15 Things to Know Before Requesting Ozempic for Weight Loss Confirm sterile compounding practices Injectable medications require strict sterile protocols to prevent contamination and infection
Fulfillment still depends on eligibility, payment completion, and clinical approval
More importantly, the first 12 weeks establish the foundation for continued progress